Azienda Socio Sanitaria Territoriale Lariana
- Address
- lock Available on a paid plan
Cardiovascular Diseases and Kidney Health
At Azienda Socio Sanitaria Territoriale Lariana in Como, clinical research in cardiovascular disease is closely linked with chronic kidney disease and hypertension. These studies are focused on understanding whether new treatment approaches can better protect the heart and kidneys, while lowering the risk of serious events such as heart failure, stroke, or cardiovascular death.
- Research on kidney disease progression and prevention of heart failure and heart-related death
- Studies in hypertension, established cardiovascular disease, and high cardiovascular risk
- Evaluation of new therapies aimed at improving cardiorenal protection
This area reflects a strong interest in testing treatments that may improve long-term outcomes for people living with overlapping heart and kidney conditions.
Neoplasms in Breast and Gynecologic Cancer
The site is also active in oncology, with trials studying breast cancer, ovarian cancer, and locally advanced cervical carcinoma. The research is aimed at improving disease control, reducing recurrence, and evaluating whether newer therapies can strengthen outcomes after standard treatment.
- Studies in triple negative breast cancer focused on improving disease-free survival
- Research in low-grade serous ovarian carcinoma exploring better tumor control
- Trials in cervical carcinoma assessing treatment activity and response
This clinical research combines immunotherapy, hormonal treatment, and other cancer-directed strategies to support more effective care for patients with difficult-to-treat tumors.
Female Urogenital Diseases and Reproductive Physiology
Research in this field covers female urogenital conditions and related reproductive and urinary physiology, with a particular focus on cancers affecting the female reproductive system. The studies are designed to refine treatment choices and improve outcomes for patients with advanced or high-risk disease.
- Work on ovarian carcinoma and cervical cancer
- Evaluation of therapies intended to improve response rates and survival
- Clinical research supporting better management of gynecologic malignancies
The research portfolio highlights efforts to improve care for women with cancers that often require carefully tailored treatment strategies.
Integrated Treatment Strategies Across Chronic and Cancer Care
The clinical trials at this hospital/clinic facility show a broad interest in comparing established treatments with newer options across both cardiometabolic and oncology care. The overall goal is to determine which approaches are most effective in preventing complications, slowing disease progression, and supporting longer-term patient health.
- Testing whether new medicines can better reduce cardiovascular events
- Comparing treatment combinations in breast cancer care
- Evaluating therapies that may improve outcomes in gynecologic cancers
This mix of studies suggests a site with experience in both chronic disease management and advanced cancer research, supported by multiple investigators and a focused Area Medica program.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Alnylam Pharmaceuticals Inc.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Socio Sanitaria Territoriale Lariana
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE IV TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB AS MAINTENANCE FRONTLINE TREATMENT OF HRD POSITIVE OVARIAN TUMOURS (IOLANTHE) | Istituto Di Ricerche Farmacologiche Mario Negri | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2023-06-16 | 2024-12-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.